These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 21070745)

  • 1. A site-specific genomic integration strategy for sustained expression of glucagon-like peptide-1 in mouse muscle for controlling energy homeostasis.
    Liu R; Li Y; Hu R; Jin T; Deng S; Liang W; Zhang N; Chen J; Prud'homme GJ; Jia WW; Ma D; Wang Q
    Biochem Biophys Res Commun; 2010 Dec; 403(2):172-7. PubMed ID: 21070745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy of diabetes using a novel GLP-1/IgG1-Fc fusion construct normalizes glucose levels in db/db mice.
    Kumar M; Hunag Y; Glinka Y; Prud'homme GJ; Wang Q
    Gene Ther; 2007 Jan; 14(2):162-72. PubMed ID: 16943856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 16-bp RBE element mediated Rep-dependent site-specific integration in AAVS1 transgenic mice for expression of hFIX.
    Xu ZX; Chen JZ; Yue YB; Zhang JQ; Li ZH; Feng DM; Ruan ZC; Tian L; Xue JL; Wang QJ; Jia W
    Gene Ther; 2009 May; 16(5):589-95. PubMed ID: 19242526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 16bp Rep binding element is sufficient for mediating Rep-dependent integration into AAVS1.
    Feng D; Chen J; Yue Y; Zhu H; Xue J; Jia WW
    J Mol Biol; 2006 Apr; 358(1):38-45. PubMed ID: 16516232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoviral vector-mediated glucagon-like peptide 1 gene therapy improves glucose homeostasis in Zucker diabetic fatty rats.
    Lee Y; Kwon MK; Kang ES; Park YM; Choi SH; Ahn CW; Kim KS; Park CW; Cha BS; Kim SW; Sung JK; Lee EJ; Lee HC
    J Gene Med; 2008 Mar; 10(3):260-8. PubMed ID: 18085721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered glucagon-like peptide-1-producing hepatocytes lower plasma glucose levels in mice.
    Riedel MJ; Lee CW; Kieffer TJ
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E936-44. PubMed ID: 19190262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo expression of GLP-1/IgG-Fc fusion protein enhances beta-cell mass and protects against streptozotocin-induced diabetes.
    Soltani N; Kumar M; Glinka Y; Prud'homme GJ; Wang Q
    Gene Ther; 2007 Jun; 14(12):981-8. PubMed ID: 17410180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted transgene integration into transgenic mouse fibroblasts carrying the full-length human AAVS1 locus mediated by HSV/AAV rep(+) hybrid amplicon vector.
    Bakowska JC; Di Maria MV; Camp SM; Wang Y; Allen PD; Breakefield XO
    Gene Ther; 2003 Sep; 10(19):1691-702. PubMed ID: 12923568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DsAAV8-mediated expression of glucagon-like peptide-1 in pancreatic beta-cells ameliorates streptozotocin-induced diabetes.
    Riedel MJ; Gaddy DF; Asadi A; Robbins PD; Kieffer TJ
    Gene Ther; 2010 Feb; 17(2):171-80. PubMed ID: 19865180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis.
    Lee YS; Shin S; Shigihara T; Hahm E; Liu MJ; Han J; Yoon JW; Jun HS
    Diabetes; 2007 Jun; 56(6):1671-9. PubMed ID: 17369525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors.
    Recchia A; Perani L; Sartori D; Olgiati C; Mavilio F
    Mol Ther; 2004 Oct; 10(4):660-70. PubMed ID: 15451450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective and safe gene-based delivery of GLP-1 using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of type 2 diabetes.
    Jean M; Alameh M; Buschmann MD; Merzouki A
    Gene Ther; 2011 Aug; 18(8):807-16. PubMed ID: 21412280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transient expression of mRNA coding for Rep protein from AAV facilitates targeted plasmid integration.
    Howden SE; Voullaire L; Vadolas J
    J Gene Med; 2008 Jan; 10(1):42-50. PubMed ID: 18001001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the subchronic antidiabetic effects of DPP IV-resistant GIP and GLP-1 analogues in obese diabetic (ob/ob) mice.
    Irwin N; McClean PL; Flatt PR
    J Pept Sci; 2007 Jun; 13(6):400-5. PubMed ID: 17486662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of therapeutic potentials of site-specific PEGylated glucagon-like peptide-1 isomers as a type 2 anti-diabetic treatment: Insulinotropic activity, glucose-stabilizing capability, and proteolytic stability.
    Youn YS; Chae SY; Lee S; Jeon JE; Shin HG; Lee KC
    Biochem Pharmacol; 2007 Jan; 73(1):84-93. PubMed ID: 17054919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-specific, Rep-mediated integration of the intact beta-globin locus in the human erythroleukaemic cell line K562.
    Howden SE; Voullaire L; Wardan H; Williamson R; Vadolas J
    Gene Ther; 2008 Oct; 15(20):1372-83. PubMed ID: 18496574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression, purification, and C-terminal site-specific PEGylation of cysteine-mutated glucagon-like peptide-1.
    Gao M; Tian H; Ma C; Gao X; Guo W; Yao W
    Appl Biochem Biotechnol; 2010 Sep; 162(1):155-65. PubMed ID: 19728172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the cellular and biological properties of DPP-IV-resistant N-glucitol analogues of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.
    Green BD; Gault VA; O'Harte FP; Flatt PR
    Diabetes Obes Metab; 2005 Sep; 7(5):595-604. PubMed ID: 16050953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
    Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
    Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An efficient GLP-1 expression system using two-step transcription amplification.
    Lee M; Oh S; Ahn CH; Kim SW; Rhee BD; Ko KS;
    J Control Release; 2006 Oct; 115(3):316-21. PubMed ID: 17045357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.